Press releases.
Press releases 2018
Press releases 2018
Operational Update
November 1st 2018
Immutep Announces Data Presentations at Upcoming Industry Conferences
October 24th 2018
Immutep to Present at Ladenburg Thalmann 2018 Healthcare Conference
September 26th 2018
Progress Towards Clinical Development of IMP761 - A LAG-3 Agonist Antibody
September 3rd 2018
TACTI-mel Patient Recruitment Complete and Operational Update
August 7th 2018
Immutep to Present at 2018 ASCO Annual Meeting
May 4th 2018
Operational Update
April 2nd 2018
Immutep Commences Patient Dosing In Additional TACTI-mel Cohort
March 21st 2018
Immutep Raises A$6.85M Through Institutional Placement
March 11th 2018
Immutep receives A$686,704 R&D Tax Incentive
March 4th 2018